1. Multiple Myeloma: Enhancing Communication With Your Patient For Optimal Outcomes

2. This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were presented in abstract form. These data should be considered preliminary until published in a peer-reviewed journal.

4. Framework for Discussing Multiple Myeloma Treatment With Patients

5. Team-Based Approach

6. Practice Pearls for Patient Communication

7. Key Communication Points in Initial And Maintenance Therapy for Multiple Myeloma

8. Be Prepared for Complex Questions

9. Tools for Optimizing Adherence

10. Selecting Treatment for Relapsed Multiple Myeloma is Complex

11. Implementing Shared Decision-Making in Multiple Myeloma Treatment

12. Encouraging Communication During Therapy

13. Key Takeaways

14. Abbreviations

15. Abbreviations (cont)